China plans to extend import VAT breaks on cancer and rare disease drugs until the end of 2027

China's decision to extend import VAT breaks on cancer and rare disease drugs until 2027 signals a long-term commitment to supporting healthcare access.

Newsquawk StaffPublished On the live feed at 7 more headlines followed before this page went public
Newsquawk headlinesUTC

SHFE is adjusting the automatic conversion standard for hedging position limits in silver futures

Newsquawk Bond Auction Previews - 11th February 2026

China plans to extend import VAT breaks on cancer and rare disease drugs until the end of 2027

Siemens Energy (ENR GY) CEO says that they have not seen data centre cancellations - Bloomberg TV

CPCA reports that from the 1-8th February, sales of passenger vehicles nationwide reached 328k Y/Y, a 54% increase

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This move may incentivize pharmaceutical investments and align with broader health policy objectives, impacting the balance of trade and potentially benefiting companies involved in these sectors.

Related headlines

The whole workspace, free to try.

Try it free